COCH transgene expression in cultured human trabecular meshwork cells and its effect on outflow facility in monkey organ cultured anterior segments

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 4, 2010, Pages 2060-2066

  Lee, Eun Suk ^a,b,e   Gabelt, B'ann T ^a   Faralli, Jennifer A ^a   Peters, Donna M ^a   Brandt, Curtis R ^a,c   Kaufman, Paul L ^a   Bhattacharya, Sanjoy K ^d  

^a University of Wisconsin   (United States)

^b Yonsei University College of Medicine   (South Korea)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COCHLIN; GREEN FLUORESCENT PROTEIN; COCH PROTEIN, HUMAN; PROTEIN;

ANIMAL TISSUE; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR OUTFLOW; ARTICLE; CELL STRUCTURE; COCH GENE; CONTROLLED STUDY; CULTURE MEDIUM; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSDUCTION; HAPLORHINI; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE TEST; INTRAOCULAR PRESSURE; MICROSCOPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRABECULAR MESHWORK; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; ADENOVIRUS; ADOLESCENT; ADULT; ANIMAL; AQUEOUS HUMOR; CELL CULTURE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; MACACA; MALE; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; SECRETION;

ADENOVIRIDAE; ADOLESCENT; ADULT; ANIMALS; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; MACACA FASCICULARIS; MACACA MULATTA; MALE; ORGAN CULTURE TECHNIQUES; PROTEINS; TRABECULAR MESHWORK; TRANSFECTION; TRANSGENES;

EID: 77951217874     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4521     Document Type: Article

References (42)

1. Quigley H.A, Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000; 130:429-440.
3. Kass M.A, Heuer D.K, Higginbotham E.J, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713;discussion 829-30.
4. Le A, Mukesh B.N, McCarty C.A, Taylor H.R. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci. 2003;44:3783-3789.
5. Heijl A, Leske M.C, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
6. Morrison J.C, Acott T.S. Anatomy and physiology of aqueous humor outflow. In: Morrison JC, Pollack IP, eds. Glaucoma Science and Practice. New York: Thieme Medical Publishers, Inc.; 2003;34-41.
7. Acott T.S, Kelley M.J. Extracellular matrix in the trabecular meshwork. Exp Eye Res. 2008;86:543-561.
8. Robertson N.G, Hamaker S.A, Patriub V, Aster J.C, Morton C.C. Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9. J Med Genet. 2003;40: 479-486.
9. Bhattacharya S.K, Rockwood E.J, Smith S.D, et al. Proteomics reveals cochlin deposits associated with glaucomatous trabecular meshwork. J Biol Chem. 2005;280:6080-6084.
10. Bhattacharya SK, Annangudi SP, Salomon RG, Kuchtey RW, Peachey NS, Crabb JW. Cochlin deposits in the trabecular meshwork of the glaucomatous DBA/2J mouse. Exp Eye Res. 2005;80: 741-744.
11. Robertson N.G, Lu L, Heller S, et al. Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat Genet. 1998;20:299-303.
12. Robertson N.G, Skvorak A.B, Yin Y, et al. Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics. 1997;46:345-354.
13. Shankaran H, Alexandridis P, Neelamegham S. Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood. 2003;101:2637-2645.
14. Robertson N.G, Cremers C.W, Huygen P.L, et al. Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction. Hum Mol Genet. 2006;15:1071-1085.
15. Picciani R, Desai K, Guduric-Fuchs J, Cogliati T, Morton C.C, Bhattacharya S.K. Cochlin in the eye: functional implications. Prog Retin Eye Res. 2007;26:453-469.
16. Bischoff A.M, Pauw R.J, Huygen P.L, et al. Vertical corneal striae in families with autosomal dominant hearing loss: DFNA9/COCH. Am J Ophthalmol. 2007;143:847-852.
17. Bhattacharya S.K, Gabelt B.T, Ruiz J, Picciani R, Kaufman P.L. Cochlin expression in anterior segment organ culture models after TGFbeta2 treatment. Invest Ophthalmol Vis Sci. 2009;50:551-559.
18. Graham F.L, van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973;52:456-467.
19. Polansky J.R, Weinreb R.N, Baxter J.D, Alvarado J. Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci. 1979;18:1043-1049.
20. Polansky J.R, Weinreb R, Alvarado J.A. Studies on human trabecular cells propagated in vitro. Vision Res. 1981;21:155-160.
21. Filla M.S, David G, Weinreb R.N, Kaufman P.L, Peters D.M. Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2. Exp Eye Res. 2004;79:61-74.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
23. Hu Y, Gabelt B.T, Kaufman P.L. Monkey organ-cultured anterior segments: technique and response to H-7. Exp Eye Res. 2006;82: 1100-1108.
24. Barany EH. Simultaneous measurement of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest Ophthalmol. 1964;3:135-143.
25. Ikezono T, Shindo S, Li L, et al. Identification of a novel cochlin isoform in the perilymph: insights to cochlin function and the pathogenesis of DFNA9. Biochem Biophys Res Commun. 2004; 314:440-446.
26. Sekine K, Ikezono T, Matsumura T, et al. Expression of cochlin mRNA splice variants in the inner ear. Audiol Neurootol. 2009;15: 88-96.
27. Gottanka J, Chan D, Eichhorn M, Lütjen-Drecoll E, Ethier CR. Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci. 2004;45:153-158.
28. Fleenor D.L, Shepard A.R, Hellberg P.E, Jacobson N, Pang I.H, Clark A.F. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci. 2006;47:226-234.
29. Wordinger R.J, Fleenor D.L, Hellberg P.E, et al. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci. 2007;48:1191-1200.
30. Borras T, Rowlette L.L, Erzurum S.C, Epstein D.L. Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow: relevance for potential gene therapy of glaucoma. Gene Ther. 1999;6:515-524.
31. Ethier C.R, Wada S, Chan D, Stamer W.D. Experimental and numerical studies of adenovirus delivery to outflow tissues of perfused human anterior segments. Invest Ophthalmol Vis Sci. 2004;45: 1863-1870.
32. Buie L.K, Rasmussen C, Porterfield E.C, et al. Self-complementary AAV virus (scAAV) override AAV transduction inability and confer long-term expression to the trabecular meshwork of living animals. Invest Ophthalmol Vis Sci. 2010;51:236-248.
33. Borras T, Xue W, Choi V.W, et al. Mechanisms of AAV transduction in glaucoma-associated human trabecular meshwork cells. J Gene Med. 2006;8:589-602.
34. Barraza R.A, Rasmussen C.A, Loewen N, et al. Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates. Hum Gene Ther. 2009;20:191-200.
35. Tian B, Hu Y, Gabelt B.T, Kaufman P.L. Factors affecting outflow facility calculations. Exp Eye Res. 2006;83:1515-1520.
36. Chi A, Valencia J.C, Hu Z.Z, et al. Proteomic and bioinformatics characterization of the biogenesis and function of melanosomes. J Proteome Res. 2006;5:3135-3144.
37. de Graauw M, Tijdens I, Smeets M.B, et al. Annexin A2 phosphorylation mediates cell scattering and branching morphogenesis via cofilin activation. Mol Cell Biol. 2008;28:1029-1040.
38. Fautsch M.P, Bahler C.K, Jewison D.J, Johnson D.H. Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment. Invest Ophthalmol Vis Sci. 2000;41:4163-4168.
39. Fautsch M.P, Bahler C.K, Vrabel A.M, et al. Perfusion of his-tagged eukaryotic myocilin increases outflow resistance in human anterior segments in the presence of aqueous humor. Invest Ophthalmol Vis Sci. 2006;47:213-221.
40. Poeschla E.M, Barraza R.A, Rasmussen C, et al. Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of non-human primates. Hum Gene Ther. 2009;20(3): 191-200.
41. Verma I.M, Weitzman M.D. Gene therapy: twenty-first century medicine. Annu Rev Biochem. 2005;74:711-738.
42. Mallam J.N, Hurwitz M.Y, Mahoney T, Chevez-Barrios P, Hurwitz R.L. Efficient gene transfer into retinal cells using adenoviral vectors: dependence on receptor expression. Invest Ophthalmol Vis Sci. 2004;45:1680-1687.